5ml of tirzepatide 179.00 | --- 45 mg / 2.5 ml --- 2.5 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) while decreasing the production of glucagon Mounjaro (Tirzepatide) Injection 5 mg/0.5

Many patients report reduced appetite and food cravings by day 35, even before any weight loss appears on the scale

Cost considerations may influence treatment decisions and adherence for some individuals, particularly those on fixed incomes or with limited financial resources

Weight loss medication can help, but it can also interact with an already strained relationship with food

If you are currently on a GLP-1 medication, paying out of pocket, or wondering whether to start, understanding this patent landscape directly affects your options and your costs

In subgroup analyses, no statistical heterogeneity was reported between patients in primary or secondary prevention or when considering the baseline HbA1c